LEXARIA BIOSCIENCE CORP. (LEXX) Shareholder Equity
- 2026-05-31: Common Stock, Value, IssuedUSD $24.79K; Additional Paid in CapitalUSD $73.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-46.47K; Retained Earnings (Accumulated Deficit)USD $-68.50M.
- 2026-02-28: Common Stock, Value, IssuedUSD $24.89K; Additional Paid in CapitalUSD $73.14M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-55.44K; Retained Earnings (Accumulated Deficit)USD $-66.51M.
- 2025-11-30: Common Stock, Value, IssuedUSD $22.23K; Additional Paid in CapitalUSD $70.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-76.08K; Retained Earnings (Accumulated Deficit)USD $-65.06M.
- 2025-08-31: Common Stock, Value, IssuedUSD $19.56K; Additional Paid in CapitalUSD $66.50M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-70.33K; Retained Earnings (Accumulated Deficit)USD $-63.46M.
LEXARIA BIOSCIENCE CORP. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Retained Earnings, Appropriated USD | Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Redeemable USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $24.79K | $73.26M | $-46.47K | $-68.50M | $4.74M | $4.34M | 3 month · $92.94K | (m) | (m) |
| 2026-02-28 | $24.89K | $73.14M | $-55.44K | $-66.51M | $6.60M | $6.21M | 3 month · $74.89K | (m) | (m) |
| 2025-11-30 | $22.23K | $70.02M | $-76.08K | $-65.06M | $4.91M | $4.52M | 3 month · $74.89K | (m) | (m) |
| 2025-08-31 | $19.56K | $66.50M | $-70.33K | $-63.46M | $2.99M | $2.60M | 12 month · $635.49K | (m) | (m) |
| 2025-05-31 | $19.56K | $66.38M | $-81.07K | $-60.76M | $5.55M | $5.17M | 3 month · $470.14K | (m) | (m) |
| 2025-02-28 | $17.56K | $64.22M | $-118.25K | $-56.98M | $7.14M | $6.76M | (m) | (m) | (m) |
| 2024-11-30 | $17.45K | $64.04M | $-22.99K | $-54.26M | $9.77M | $9.39M | 3 month · $99.42K | (m) | (m) |
| 2024-08-31 | $15.81K | $59.60M | $-19.82K | $-51.56M | $8.04M | $7.66M | 12 month · $492.24K | (m) | (m) |
| 2024-05-31 | $15.81K | $59.50M | $-21.87K | $-49.37M | $10.12M | $9.75M | 3 month · $341.77K | $49.40M | (m) |
| 2024-02-29 | $12.39K | $54.12M | $-20.63K | $-47.59M | $6.52M | $6.15M | (m) | $47.60M | (m) |
| 2023-11-30 | $10.31K | $50.67M | $4.37K | $-46.94M | $3.74M | $3.37M | 3 month · $53.95K | (m) | (m) |
| 2023-08-31 | $8.09K | $48.80M | $0.00 | $-45.76M | $3.04M | $2.68M | 12 month · $0.00 | (m) | (m) |
| 2023-05-31 | $8.09K | $48.91M | (m) | $-44.52M | $4.40M | $4.04M | (m) | (m) | (m) |
| 2023-02-28 | $5.95K | $47.12M | (m) | $-42.15M | $4.97M | $4.63M | (m) | (m) | (m) |
| 2022-11-30 | $5.95K | $47.11M | (m) | $-40.85M | $6.26M | $5.93M | (m) | (m) | (m) |
| 2022-08-31 | $5.95K | $47.04M | (m) | $-39.10M | $7.95M | $7.63M | 12 month · $278.11K | (m) | (m) |
| 2022-05-31 | $5.95K | $46.81M | (m) | $-37.63M | $9.18M | $8.91M | 3 month · $111.17K | (m) | (m) |
| 2022-02-28 | $5.95K | $46.70M | (m) | $-35.25M | $11.22M | $11.22M | (m) | (m) | (m) |
| 2021-11-30 | $5.73K | $45.50M | (m) | $-33.82M | $11.47M | $11.47M | 3 month · $408.54K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | $11.47M | 1 month · $408.54K | (m) | (m) |
| 2021-08-31 | $5.73K | $45.09M | (m) | $-31.83M | $13.06M | $13.06M | 12 month · $410.01K | (m) | (m) |
| 2021-05-31 | $5.10K | $40.99M | (m) | $30.60M | $10.27M | $10.27M | 3 month · $343.97K 9 month · $410.01K | (m) | (m) |
| 2021-02-28 | $5.10K | $39.86M | (m) | $-28.09M | $11.70M | $11.70M | 3 month · $17.15K | (m) | (m) |
| 2020-11-30 | $3.00K | $30.37M | (m) | $-28.50M | $1.82M | $1.82M | 3 month · $48.89K | (m) | (m) |
| 2020-08-31 | $3.00K | $30.32M | (m) | $-27.80M | $2.48M | $2.48M | 12 month · $1.14M | (m) | (m) |
| 2020-05-31 | $89.59K | $30.18M | (m) | $-27.09M | $3.20M | $3.20M | 3 month · $682.56K 9 month · $1.14M | (m) | (m) |
| 2020-02-29 | $80.72K | $27.52M | (m) | $-25.73M | $1.92M | $1.92M | 3 month · $294.29K | (m) | (m) |
| 2019-11-30 | $80.61K | $27.22M | (m) | $-24.78M | $2.62M | $2.62M | 3 month · $162.41K | (m) | (m) |
| 2019-08-31 | $78.79K | $26.17M | (m) | $-23.87M | $2.49M | $2.49M | 3 month · $119.38K 12 month · $626.69K | (m) | (m) |
| 2019-05-31 | $78.44K | $25.89M | (m) | $-22.79M | $3.32M | $3.32M | 3 month · $443.27K | (m) | (m) |
| 2019-02-28 | $78.00K | $24.32M | (m) | $-21.62M | $3.77M | $3.77M | (m) | (m) | (m) |
| 2018-11-30 | $77.12K | $23.81M | (m) | $-20.47M | $3.41M | $3.41M | 3 month · $64.04K | (m) | (m) |
| 2018-08-31 | $75.53K | $22.10M | $-14.25K | $-19.77M | $2.39M | $2.39M | 3 month · $499.54K 12 month · $2.60M | (m) | (m) |
| 2018-05-31 | $72.40K | $21.12M | $-7.38K | $-18.55M | $2.64M | $2.64M | 3 month · $1.98M 9 month · $2.10M | (m) | (m) |
| 2018-02-28 | $71.10K | $17.83M | (m) | $-15.13M | $2.77M | $2.77M | 3 month · $122.56K 6 month · $122.56K | (m) | (m) |
| 2017-11-30 | $69.44K | $16.08M | (m) | $-13.75M | $2.40M | $2.40M | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | $2.77M | (m) | (m) | (m) | (m) |
| 2017-08-31 | $67.98K | $16.11M | $0.00 | $-13.17M | $2.77M | $2.77M | 12 month · $93.97K | (m) | (m) |
| 2017-05-31 | $66.55K | $15.68M | (m) | $-12.48M | $3.26M | $3.06M | 9 month · $17.57K | (m) | (m) |
| 2017-02-28 | $56.29K | $12.78M | (m) | $-12.14M | $691.17K | $490.57K | 6 month · $17.57K | (m) | (m) |
| 2016-11-30 | $55.01K | $12.45M | (m) | $-11.70M | $806.74K | $623.34K | 3 month · $17.57K | (m) | (m) |
| 2016-08-31 | $51.29K | $11.52M | (m) | $-11.30M | $266.05K | $87.76K | 12 month · $83.86K | (m) | (m) |
| 2016-05-31 | $45.51K | $11.06M | (m) | $-10.99M | $120.69K | $-45.28K | 9 month · $51.64K | (m) | (m) |
| 2016-02-29 | $44.55K | $10.95M | (m) | $-10.73M | $264.95K | $105.15K | (m) | (m) | (m) |
| 2015-11-30 | $39.95K | $10.86M | (m) | $-10.47M | $463.81K | $318.73K | (m) | (m) | (m) |
| 2015-08-31 | $43.84K | $10.81M | (m) | $-10.09M | $772.41K | $656.60K | 12 month · $197.00K | (m) | (m) |
| 2015-05-31 | $39.68K | $10.68M | (m) | $-9.57M | $1.15M | $1.14M | (m) | (m) | (m) |
| 2015-02-28 | $34.68K | $10.21M | (m) | $-9.10M | $1.14M | $1.17M | (m) | (m) | (m) |
| 2014-11-30 | $34.44K | $10.04M | (m) | $-8.66M | $1.42M | $1.46M | (m) | (m) | (m) |
| 2014-08-31 | $34.25K | $10.03M | (m) | $-8.32M | $1.72M | $1.72M | (m) | (m) | (m) |
| 2014-07-31 | $32.82K | $9.75M | (m) | $-6.23M | $3.55M | (m) | (m) | (m) | 3 month · $8.41K 9 month · $8.41K |
| 2014-04-30 | $31.84K | $9.35M | (m) | $-5.65M | $3.73M | (m) | (m) | (m) | (m) |
| 2014-01-31 | $16.93K | $7.17M | (m) | $-5.16M | $2.03M | (m) | (m) | (m) | (m) |
| 2013-10-31 | $16.43K | $7.14M | (m) | $-5.06M | $2.10M | $2.10M | (m) | (m) | (m) |
| 2013-07-31 | $16.43K | $7.14M | (m) | $-4.93M | $2.23M | (m) | (m) | (m) | 3 month · $0.00 9 month · $0.00 |
| 2013-04-30 | $16.43K | $7.12M | (m) | $-4.87M | $2.26M | (m) | (m) | (m) | (m) |
| 2013-01-31 | $16.43K | $7.12M | (m) | $-4.83M | $2.31M | (m) | (m) | (m) | (m) |
| 2012-10-31 | $16.43K | $7.12M | (m) | $-4.71M | $2.42M | (m) | (m) | (m) | (m) |
| 2012-07-31 | $16.43K | $7.12M | (m) | $-4.75M | $2.39M | (m) | (m) | (m) | (m) |
| 2012-04-30 | $16.43K | $7.12M | (m) | $-4.81M | $2.32M | (m) | (m) | (m) | (m) |
| 2012-01-31 | $16.43K | $7.12M | (m) | $-4.58M | $2.55M | (m) | (m) | (m) | (m) |
| 2011-10-31 | $16.43K | $7.11M | (m) | $-4.46M | $2.66M | (m) | (m) | (m) | (m) |
| 2011-07-31 | $15.63K | $6.84M | (m) | $-4.46M | $2.39M | (m) | (m) | (m) | (m) |
| 2010-10-31 | $12.93K | $6.07M | (m) | $-3.92M | $2.15M | (m) | (m) | (m) | (m) |
| 2009-10-31 | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) | (m) |
| 2009-10-30 | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |